The downregulation of ZKSCAN3 by these miRNAs occurs predominantly in specific cancer types and stages, highlighting a context-dependent regulatory framework that maintains the balance of ZKSCAN3’s oncogenic functions. This evidence concerns the gene ZKSCAN3 and cancer.